Cardiff Oncology, Inc. (CRDF)
NASDAQ: CRDF · Real-Time Price · USD
3.740
+0.535 (16.69%)
At close: Nov 4, 2024, 4:00 PM
3.690
-0.050 (-1.34%)
After-hours: Nov 4, 2024, 4:47 PM EST
Cardiff Oncology Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Nov '24 Nov 4, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Market Capitalization | 174 | 66 | 63 | 252 | 635 | 10 | |
Market Cap Growth | 51.18% | 5.71% | -75.20% | -60.31% | 6519.33% | -20.54% | |
Enterprise Value | 116 | -13 | -49 | 121 | 600 | 2 | |
Last Close Price | 3.74 | 1.48 | 1.40 | 6.01 | 17.99 | 1.24 | |
PE Ratio | - | -1.59 | -1.57 | -8.28 | -16.62 | -0.44 | |
PS Ratio | 251.48 | 135.50 | 162.04 | 702.51 | 1736.31 | 39.24 | |
PB Ratio | 3.26 | 0.95 | 0.59 | 1.80 | 4.96 | 1.31 | |
P/FCF Ratio | -3.06 | -2.10 | -1.80 | -10.85 | -38.45 | -0.72 | |
P/OCF Ratio | -3.10 | -2.14 | -1.85 | -10.95 | -38.95 | -0.72 | |
EV/Sales Ratio | 173.86 | -26.53 | -126.70 | 338.28 | 1640.66 | 10.20 | |
EV/EBITDA Ratio | -0.77 | 0.29 | 1.23 | -4.28 | -32.25 | -0.15 | |
EV/EBIT Ratio | -0.76 | 0.29 | 1.23 | -4.21 | -31.46 | -0.15 | |
EV/FCF Ratio | -1.05 | 0.41 | 1.40 | -5.22 | -36.34 | -0.19 | |
Debt / Equity Ratio | 0.04 | 0.03 | 0.03 | 0.02 | 0.01 | 0.24 | |
Debt / FCF Ratio | -0.06 | -0.07 | -0.08 | -0.13 | -0.05 | -0.13 | |
Asset Turnover | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | |
Quick Ratio | 4.85 | 7.19 | 13.58 | 21.55 | 21.46 | 2.17 | |
Current Ratio | 4.97 | 7.41 | 14.25 | 22.28 | 21.79 | 2.37 | |
Return on Equity (ROE) | -58.80% | -47.07% | -31.37% | -21.07% | -28.50% | -188.72% | |
Return on Assets (ROA) | -34.12% | -28.69% | -18.77% | -12.69% | -16.14% | -76.48% | |
Return on Capital (ROIC) | -38.95% | -31.37% | -19.75% | -13.23% | -17.28% | -109.03% | |
Earnings Yield | -23.48% | -62.67% | -61.88% | -11.22% | -3.04% | -170.97% | |
FCF Yield | -18.65% | -47.59% | -55.68% | -9.22% | -2.60% | -138.90% | |
Buyback Yield / Dilution | -0.93% | -2.47% | -11.71% | -86.97% | -249.44% | -156.37% | |
Total Shareholder Return | -0.93% | -2.47% | -11.71% | -86.97% | -249.44% | -156.37% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.